Clinical Trials Logo

Filter by:
NCT ID: NCT00868153 Completed - Clinical trials for Idiopathic Menorrhagia

Mirena in Idiopathic Menorrhagia

Start date: August 2004
Phase: N/A
Study type: Observational

This is an open-label, uncontrolled, multi-centre observational study that analyses a follow-up of 1600 women with dysfunctional uterine bleeding (idiopathic menorrhagia) over a period of one year.The patients evaluated at four visits, beginning with the insertion visit and 3, 6 and 12 months after insertion.

NCT ID: NCT00862732 Not yet recruiting - Clinical trials for Active Suicidal Ideations

Study to Prevent Negative Thoughts of Life

Start date: March 2009
Phase: N/A
Study type: Interventional

The purpose of the study is to test whether cognitive behaviour therapy (CBT) offered by trained therapists, to people with current active suicidal ideations, is efficacious as a secondary prevention strategy in Sri Lanka, when compared with treatment as usual provided by Medical Officers (Mental Health; MO (MH)) of government hospitals

NCT ID: NCT00854685 Completed - Clinical trials for Rheumatoid Arthritis

Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate

Start date: February 2009
Phase: Phase 2
Study type: Interventional

The purpose of this clinical trial is to establish what dose level and dosing frequency is optimal in the treatment of rheumatoid arthritis patients with ART621.

NCT ID: NCT00779779 Completed - Clinical trials for Infections, Rotavirus

Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants

Start date: November 22, 2008
Phase:
Study type: Observational

This Post Marketing Surveillance (PMS) will collect reactogenicity and safety data on the use of human rotavirus vaccine in healthy infants aged from 6 weeks (first dose) to not more than 24 weeks (second dose).

NCT ID: NCT00567307 Completed - Clinical trials for Cardiovascular Disease

Polypill For Prevention of Cardiovascular Disease

Start date: January 2009
Phase: Phase 2
Study type: Interventional

The purpose of this pilot study is to provide data on the feasibility of conducting a large clinical trial on the polypill (combination of aspirin, angiotensin converting enzyme inhibitor, thiazide diuretic, and statin) for primary prevention of cardiovascular disease (CVD). We hypothesized that A "polypill" comprising the aforementioned four components would significantly reduce the estimated 10-year total CVD risk score with high adherence and no significant increase in adverse effects compared to the standard practice.

NCT ID: NCT00565708 Active, not recruiting - Colorectal Cancer Clinical Trials

Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers

ASCOLT
Start date: December 2008
Phase: Phase 3
Study type: Interventional

We hypothesize through this randomized, placebo-controlled adjuvant study, that Aspirin in patients with dukes C or high risk dukes B colorectal cancer (ASCOLT) can improve survival in this patient population over placebo control. If indeed found to be beneficial, because aspirin is cheap and easy to administer, it will positively impact the lives of many individuals in Asia and globally. STUDY OBJECTIVE To assess the effectiveness of Aspirin against placebo control in patients with dukes C or high risk dukes B colorectal cancer in terms of Disease Free Survival (DFS) and Overall Survival (OS) Primary endpoints - DFS among all eligible subjects (high risk Dukes B colon cancer, Dukes C colon cancer and rectal cancer patient sub-groups); - DFS among patients with colon cancer (high-risk Dukes B and Dukes C colon cancer). Secondary endpoints - Overall survival (OS) over 5 years - DFS and OS in - Chinese, Malay, Indian and other ethnic groups - Resected high risk Dukes B colon cancer, Dukes C colon cancer and rectal cancer sub-groups, individually - Compliant versus non-compliant subjects - PIK3CA mutated tumors (where samples are available)

NCT ID: NCT00564317 Completed - Clinical trials for Post-Traumatic Stress Disorders

KIDNET vs Meditation/Relaxation - a Dissemination Randomized Controlled Trial for the Treatment of Traumatized Children After War in Sri Lanka

Start date: September 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy of KIDNET versus a Meditation/Relaxation protocol in treating traumatized children when applied by locally trained teacher counsellors as well as the effectiveness and adequacy of such a treatment in a south-asian war affected stayee child community.

NCT ID: NCT00554723 Completed - Stroke Clinical Trials

CHInese Medicine NeuroAid Efficacy on Stroke Recovery

CHIMES
Start date: May 2007
Phase: Phase 3
Study type: Interventional

CHIMES is a double blind, placebo controlled, randomized, multicenter study to test the hypothesis that NeuroAid is superior to placebo in reducing neurological deficit and improving functional outcome in patients with cerebral infarction of an intermediate range of severity.

NCT ID: NCT00476580 Withdrawn - Acculturation Clinical Trials

Health Habits and Cancer Risk Comparison Among Migrant Sri Lankans and Sri Lankans

Start date: April 2007
Phase: N/A
Study type: Observational

Objectives: General objective: To determine how acculturation to United States has influenced the health and cancer risk among a US migrant Sri Lankan population. Specific objectives: 1. To determine the prevalence of cancer and cancer related non-communicable diseases among Sri Lankan Sinhalese living in the greater Houston area. 2. To study the distribution of risk factors for cancer in this population. 3. To study the pattern of utilization of methods available for early detection of cancer in this population. 4. To study and compare the findings of this survey with that of the siblings of this population living in Sri Lanka.

NCT ID: NCT00463684 Completed - Clinical trials for Japanese Encephalitis

Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age

JEV03
Start date: July 7, 2007
Phase: Phase 4
Study type: Interventional

To facilitate introduction of live attenuated SA 14-14-2 Japanese encephalitis vaccine (LJEV) into the National Immunization Programme of Sri Lanka, we evaluated the safety and immunogenicity of co-administration of LJEV and measles vaccine at 9 months of age. The primary hypothesis was that the seropositivity rate at 28 days post vaccination in Japanese Encephalitis (JE) and measles concomitantly vaccinated subjects 9 months of age is greater than 80% for JE and greater than 90% for measles.